Medical News Today: COVID-19 misinformation was 'entirely predictable,’ experts say
UC expert commentary on study of COVID-19 misinformation compared to other health topics
In today’s world of cultural politics, UC social media expert Professor Jefferey Blevins says “It seems that a lot of people look to social media not necessarily to find the ‘truth’ about anything, but rather to find information and commentary that supports their already-held views — hence, what social scientists call ‘confirmation bias.’”
Blevins, who heads UC’s Department of Journalism, said the above in an article where expers weighed in on a recent study at George Washington University. The research found: COVID-19 posts were 1.13 times more likely to link to credible sources than health-related posts prior to the pandemic. But among the COVID-19 posts that linked to “not credible” sources, these sources were 3.67 times more likely to contain misinformation.
Blevins recently published a UC study on the spread of medical misinformation during the earlier stages of the pandemic.
Read Blevins commentary on the GWU study, which he feels documents a situation that has worsened since spring 2020.
Featued image at top of Jeffrey Blevins. Photo/UC Creative + Brand.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.